Cargando…
L-citrulline for protection of endothelial function from ADMA–induced injury in porcine coronary artery
Endogenous nitric oxide synthase (eNOS) inhibitor asymmetric dimethylarginine (ADMA) is a cardiovascular risk factor. We tested the hypothesis that L-citrulline may ameliorate the endothelial function altered by ADMA in porcine coronary artery (PCA). Myograph study for vasorelaxation, electrochemica...
Autores principales: | Xuan, Chao, Lun, Li-Min, Zhao, Jin-Xia, Wang, Hong-Wei, Wang, Jue, Ning, Chun-Ping, Liu, Zhen, Zhang, Bei-Bei, He, Guo-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457144/ https://www.ncbi.nlm.nih.gov/pubmed/26046576 http://dx.doi.org/10.1038/srep10987 |
Ejemplares similares
-
Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016) -
Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
por: Avci, Emre, et al.
Publicado: (2020) -
Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009) -
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010) -
The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
por: Lüneburg, Nicole, et al.
Publicado: (2014)